Markets & Finance

Brightline has reached a conditional restructuring support agreement with municipal bond insurer Assured Guaranty for at least $350 million in new loans, contingent on a Chapter 11 filing that people familiar with the matter estimate could come within weeks. The railroad carries roughly $5.5 billion in total obligations across multiple subsidiaries and has repeatedly extended grace periods on interest payments due across several bond series. Assured Guaranty, which insures approximately $1.13 billion of Brightline's senior bonds and holds contractual voting and consent rights over those securities, is positioned as the proposed debtor-in-possession lender, though full facility terms have not been made public.

Samsung Peptide AG has published its formal offer prospectus to acquire all publicly held shares of PolyPeptide Group AG at CHF 44.31 per share, a 40% premium to the stock's unaffected April closing price, with the main acceptance window running September 15 through October 12, 2026. The offer is effectively anchored by a binding tender commitment from Draupnir Holding B.V., PolyPeptide's largest shareholder with a 55.65% stake, putting the required 66⅔% acceptance threshold within reach before a single minority shareholder acts. If successful and regulatory conditions are met, Samsung Biologics intends to delist PolyPeptide from SIX and either cancel remaining public shares or merge the company into its Swiss subsidiary.

Multi-Color Corporation completed its prepackaged Chapter 11 restructuring on May 11, 2026, cutting net debt by approximately $3.8 billion, reducing annualized cash-interest expense by more than $330 million, and extending debt maturities to 2033. The plan was accepted by over 99% of voting stakeholders, with CD&R remaining majority owner and certain existing lenders receiving minority equity positions. Surviving debt includes $1.565 billion allocated to first-lien creditors, while existing equity interests were cancelled with zero recovery.